Size: px
Start display at page:

Download ""

Transcription

1

2

3

4

5

6 1 5

7 6 2

8 3 7

9 8 4

10 5 9

11 10 6

12 7 11

13 12 8

14 % % 9 13

15 % %, 5.0% + +, 5.0% +, 1, 5 +,

16 0% 20% 40% 60% 80% 100% n= n= % 35.0% 1 n= % 35.0% 11 15

17 2, 15.0% 5, 4 3, 5.0% 4, 4, 15.0%, 85.0% 16 12

18 % 25.0% 35.0% 5.0% 25.0% 5.0% 0% 20% 40% 60% 80% 100% n= % 10.5% n=5 8 2 n=7 28.6% 42.9% 28.6% n=1 10 n=5 2 8 n=

19 ,,, 5.0%, 95.0% % % 25.0% % 18 14

20 0% 20% 40% 60% 80% 100% n= % 5.9% 29.4% n=8 37.5% 12.5% 5 n= n= n= % 7.1% 7.1% 14.3% n=

21 , 5.0%, 45.0%, 5, 15.0%,, 85.0% 20 16

22 , 5.0%,, 3, 65.0% % 15.4% 23.1% 7.7% 17 21

23 () % () 45.0% () 9 () 15.0% 3 () () 5.0% 5.0%

24 61,, 15.0%, 31, 1, 35.0% 1,

25 % % % % 24 20

26 %

27 26 22

28 95, 13.9%, 0.3% 64, 1.2% 6569, 2.2% 7074, 5.0% 7579, 10.6% 9094, 23.3% 8084, 17.2% 8589, 26.3%, 0.1%, 19.4%, 80.5% 23 27

29 , 1.1%, 26.8%, 20.7%, 51.4%, 0.1% 1, 2.2% 2, 5.9% 3, 19.3% 5, 36.8% 4, 35.6% 28 24

30 M, 3.1%, 0.3%, 26.8%, 3.8% a, 4.4% b, 14.3% b, 10.4% a, 36.8% 0% 20% 40% 60% 80% 100% 4.3% 9.1% 17.3% 69.0% 0.3% 18.0% 27.5% 22.0% 32.2% 0.3% 4.6% 6.6% 31.3% 57.4% 0.1% 2.9% 32.7% 64.1% 0.1% 0.2% 5.6% 3.1% 35.3% 55.8% 0.3% 25 29

31 % () () 5.0% 5.2% () 11.0% () 2.6% 3.0% 24.7% 0.5% 3.9% 5.6%, 0.3%, 11.5%, 0.9%, 12.8%, 74.4% 30 26

32 1,600ml, 16.3%, 0.5% 1,000ml, 24.3% 1,300 1,600ml, 25.3% 1,000 1,300ml, 33.6% 1,500kcal, 29.4%, 0.5% 1,000kcal, 14.5% ,500kcal, 26.0% 1,000 1,300kcal, 29.6% 27 31

33 % 27.4% 8.5% 5.4% 4.1% 8.3% 6.0% 11.5% 36.9% 54.6% 14.0% 18.8% 32 28

34 % 7.1% 12.2% 23.4% 36.7% 36.4% 12.1% 1.6% 72.7% 13.8% 27.0% 2.2% 29.5% 12.7% 0.2% 0.2% 4.3% 29.0% 4.5% 0.5% 29 33

35 % 3.0% 2.2% 4.9% 3.3% 4.4% 1.9% 0.2% 17.0% 15.8% 15.1% 6.3% 4.7% 9.2% 0.4% 6.3% 10.1% 0.1% 1.7% 0.3% 34 30

36 , 6.0%, 94.0% 2.0% 4.0% 6.0% 8.0% % 14.0% 16.0% 1 7.7% % % % % % 7 7.5% 8 5.9% 9 3.6% % 6.0% 31 35

37 % 51.1% 39.9% 22.7% 17.6% 16.9% 16.1% 12.7% 10.8% 10.4% 9.4% 8.9% 8.8% 8.3% 7.8% 7.1% 6.9% 6.4% 6.3% 6.0% 5.8% 5.6% 4.7% 4.3% 3.8% 3.8% 3.5% 2.8% 2.8% 2.6% 2.4% 2.0% 1.6% 1.4% 0.9% 0.9% 0.8% 0.7% 0.5% 0.5% 0.3% 0.3% 0.2% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 6.0%

38 , 4.1%, 29.6%, 26.6%, 14.1%, 6.8%, 16.4%, 1.3%, 0.3%, 0.8% Q12.Q

39 % 0.3% 3.3% 0.2% 0.3% 0.5% 2.9% 0.1% 1.1% 15.8% 15.1% 19.5%

40 , 34.9%, 16.6%, 8.1%, 19.7%, 20.8% CT 18.4% MRI 5.6% SPECT 1.2% 6.9% 44.0% 31.1% 1 39

41 0% 20% 40% 60% 80% 100% CT n= % 64.2% 0.4% MRI n=82 3.7% 92.7% 3.7% SPECT n=17 5.9% 94.1% 40 39

42 0% 20% 40% 60% 80% 100% n= % 31.0% 22.4% 3.8% 21.9% 0.9% n= % 44.3% 20.6% 4.3% n= % 21.7% 25.7% 6.4% 31.1% 40 41

43 0% 20% 40% 60% 80% 100% n= % 23.7% 32.2% 4.3% 22.2% 2.4% n= % 31.3% 33.4% 9.4% n= % 18.5% 33.6% 6.3% 27.6% 42 41

44 0% 20% 40% 60% 80% 100% 11.1% 87.0% 2.0% 7.1% 90.8% 2.1% 1.1% 96.8% 2.1% %1 12.5%2 43.8% %5 12.5%2 43.8%

45 , 25.0% 4, 43.8% 7, 31.3% 5, 0, 8.9%, 4.1%, 87.1% 44 43

46 44 45

47 46 45

48 NPI Jeffery L. Cummings 46 47

49 48 47

50 48 49

51 5.0% % % % % A 15.9% B 14.9% C 38.6% D 17.8% E 19.6% F 9.8% G 25.7% H 11.9% I 26.0% J 16.4% K 20.7% L 17.2% 50 49

52 A n= % B n=220 C n= % 37.9% D n= % E n=289 F n= % 31.3% G n= % H n= % I n= % J n= % K n= % L n= % 50 51

53 5.0% % % % % 5 A n=235 B n= % 16.6% C n=570 D n=263 E n=289 F n= % 9.1% 11.8% 11.1% G n= % H n= % I n= % J n= % K n= % L n= % 52 51

54 5.0% % % % A n=47 2 B n= % C n=114 2 D n= % E n= % F n=10 6.9% G n=35 9.2% H n= % I n= % J n= % K n= % L n= % 52 53

55 , 0.1% NA, 14.2%, 15.9%, 69.8% % 51.9% 34.5% 22.6% 7.7% 3.0% 13.2% 3.8% 11.9% 5.1% 41.3% 28.1% 54 53

56 , 0.9% 29.8% 28.9% 31.1% 9.4% 16.6% 34.9%, 0.4% 48.1%, 9.8%, 0.4%, 10.2%, 10.2%, 22.1%, 30.6%, 16.6% 54 55

57 , 0.2% NA, 13.3%, 14.9%, 71.6% % 25.0% 26.4% 40.5% 50.5% 47.7% 64.1% 8.2% 3.6% 4.5% 1.8% 7.3% 2.3% 0.5% 0.5% 56 55

58 , 0.5%, 38.6%, 21.8%, 31.4%, 7.7% 14.5%, 1.4% 30.5% 53.6%, 10.9%, 0.9%, 7.7%, 21.8%, 13.6%, 3, 15.0% 56 57

59 NA, 9.6%, 0.1%, 38.6%, 51.7% % 68.6% 12.1% 29.5% 11.8% 41.9% 5.3% 28.6% 21.1% 9.6% 0.9% 19.6% 6.7% 12.8% 3.2% 0.5%

60 , 0.4%, 37.9%, 18.8%, 6.7%, 36.3%, 0.5% 10.5% 47.9% 41.1%, 6.3%, 0.9%, 5.6%, 13.7%, 23.9%, 26.0%, 23.7% 58 59

61 NA, 12.9%, 0.3%, 17.8%, 69.0% % 51.3% 38.0% 69.2% 8.0% 29.3% 6.1% 1.1% 7.2% 27.8% 9.5% 3.4% 10.6% 11.0% 3.4% 23.2% 0.4% 0.4% 60 59

62 , 14.4%, 0.4%, 38.4%, 37.6%, 9.1% 9.1%, 0.4% 22.8% 67.7%, 6.5%, 0.4%, 6.5%, 14.4%, 22.4%, 19.4%, 30.4% 60 61

63 NA, 12.4%, 0.5%, 19.6%, 67.5% % 23.9% 16.3% 32.9% 8.0% 6.9% 16.6% 14.5% 20.1% 11.4% 25.3% 15.9% 28.4% 18.7% 0.3% 0.3% 62 61

64 , 1.0% 32.2% 32.2% 22.5% 12.1% 11.8%, 1.4% 23.5% 63.3%, 8.0%, 1.4%, 13.1%, 6.6%, 17.3%, 32.2%, 21.5% 62 63

65 NA, 10.6%, 0.3%, 9.8%, 79.3% % 81.9% 24.3% 51.4% 10.4% 2.8% 9.0% 31.3% 4.9% 2.1% 14.6% 16.7% 0.7% 1.4% 64 63

66 , 1.4% 31.3% 21.5% 34.7% 11.1% 11.1%, 0.7% 19.4% 68.8%, 4.9%, 2.1%, 0.7%, 6.9%, 15.3%, 41.7%, 28.5% 64 65

67 NA, 11.2%, 0.2%, 25.7%, 62.9% % 69.7% 2.6% 15.6% 9.2% 8.7% 10.3% 39.8% 39.3% 40.6% 27.2% 66.8% 1.3% 1 0.5% 66 65

68 , 0.5%, 5.8%, 2.9%, 76.5%, 14.2%, 0.5%, 43.8%, 35.1%, 20.6%, 5.0%, 0.8%, 4.2%, 1, 30.3%, 14.8%, 34.8% 66 67

69 , 0.3% NA, 10.6%, 11.9%, 77.2% % 43.2% 11.4% 32.4% 40.9% 58.0% 12.5% 10.2% 3.4% 26.1% 12.5% 3.4% 14.8% 6.8% 68 67

70 ,, 19.3% 19.3%,, 36.4% 36.4%, 6.8% 6.8%,, 37.5% 37.5%,, 22.2%, 39.8%, 38.1%, 8.5%, 10.2%, 15.9%, 24.4%, 19.9%, 21.0% 68 69

71 NA, 10.4%, 0.3%, 26.0%, 63.3% % 77.9% 17.2% 15.1% % 14.3% 31.8% 4.4% 4.4% 4.2% 0.8% 0.3% 16.1% 24.2% 70 69

72 , 0.3%, 27.9%, 16.9%, 8.9%, 46.1%, 18.2%, 47.9%, 33.9%, 8.3%, 0.8%, 7.3%, 14.6%, 22.7%, 23.7%, 22.7% 70 71

73 NA, 10.7%, 0.1%, 16.4%, 72.7% % 49.2% 8.3% 26.0% 20.7% 7.4% 27.3% 16.1% 31.4% 45.5% 72 71

74 , 0.4%, 9.1%, 5.8%, 58.3%, 26.4%, 36.0%, 1.2%, 26.9%, 36.0%, 12.4%, 0.8%, 7.0%, 19.4%, 22.7%, 17.8%, 19.8% 72 73

75 NA, 8.2%, 0.1%, 20.7%, 70.9% % 46.1% 40.5% 71.6% 18.0% 31.7% 10.8% 4.6% 17.6% 3.9% 11.1% 21.2% 0.3% 1.0% 74 73

76 , 0.7%, 28.8%, 17.3%, 9.2%, 44.1%, 19.0%, 0.7% 2, 23.5%, 56.9%, 8.2%, 1.0%, 15.4%, 13.4%, 19.3%, 26.5%, 16.3% 74 75

77 , 0.2% NA, 21.8%, 17.2%, 60.9% % 37.9% 9.5% 20.6% 13.4% 8.3% 2.8% 14.2% 7.9% 11.9% 4.3% 11.5% 5.1% 33.2% 25.7% 18.6% 0.4% 76 75

78 , 0.4%, 11.1%, 2.4%, 65.2%, 20.9%, 26.1%, 0.4%, 43.9%, 29.6%, 8.7%, 0.8%, 11.1%, 12.6%, 20.2%, 25.7%, 20.9% 76 77

79 78 77

80 5.0% % % % % A 15.9% B 14.9% C 38.6% D 17.8% E 19.6% F 9.8% G 25.7% H 11.9% I 26.0% J 16.4% K 20.7% L 17.2% 78 79

81 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n= n= n= n= n= n= NA 80 79

82 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n= n= n= n= n= n= NA 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n= n= n= n= n= n= NA 80 81

83 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n= n= n= n= n= n= NA 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n= n= n= n= n= n= NA 82 81

84 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n= n= n= n= n= n= NA 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n= n= n= n= n= n= NA 82 83

85 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n= n= n= n= n= n= NA 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n= n= n= n= n= n= NA 84 83

86 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n= n= n= n= n= n= NA 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n= n= n= n= n= n= NA 84 85

87 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n= n= n= n= n= n= NA 86 85

88 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n=1, % 69.8% 14.2% 0.1% n= % 78.6% a n=65 b n= % 21.3% 81.5% 78.2% 0.5% a n= % 74.6% 10.1% b n= % 71.4% 9.1% n= % 55.2% 32.7% 0.3% n= % 65.2% 23.9% NA 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n=1,475 n= % 8.9% 71.6% 89.3% 13.3% 0.2% 1.8% a n=65 9.2% 90.8% b n= % 84.4% 0.5% a n= % 75.9% 9.6% 0.6% b n= % 73.4% 5.2% n= % 54.4% 30.9% n= % 52.2% 26.1% NA 2 87

89 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n=1, % 51.7% 9.6% 0.1% n= % 80.4% a n=65 b n= % 37.4% 70.8% 62.1% 0.5% a n= % 52.5% 7.2% b n= % 46.1% 2.6% n= % 42.0% 22.3% 0.3% n= % 34.8% 21.7% NA 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n=1, % 69.0% 12.9% 0.3% n=56 a n= % 18.5% 75.0% 81.5% b n= % 74.9% 1.4% a n= % 70.9% 8.8% 0.6% b n= % 75.3% 5.8% n= % 58.7% 30.1% 0.3% n= % 63.0% 23.9% NA 88 3

90 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n=1, % 67.5% 12.4% 0.5% n= % 67.9% 3.6% a n= % 75.4% b n= % 72.5% 0.5% 0.5% a n= % 70.2% 8.3% 0.2% b n= % 72.7% 5.8% n= % 57.7% 29.9% 0.8% n= % 65.2% 21.7% NA 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n=1, % 79.3% 10.6% 0.3% n=56 7.1% a n=65 1.5% 91.1% 98.5% 1.8% b n= % 91.9% 0.5% 0.5% a n= % 82.9% 7.6% 0.2% b n= % 79.9% 0.6% 3.2% n= % 63.5% 25.1% 0.3% n=46 8.7% 69.6% 21.7% NA 4 89

91 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n=1, % 62.9% 11.2% 0.2% n= % 85.7% 1.8% a n= % 84.6% b n= % 82.9% 0.5% a n= % 62.2% 7.7% 0.2% b n= % 63.0% 5.8% n= % 46.8% 26.1% 0.3% n= % 54.3% 21.7% NA 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n=1, % 77.2% 10.6% 0.3% n=56 a n= % 7.7% 87.5% 92.3% b n= % 84.4% 0.5% a n= % 80.8% 7.2% b n= % 82.5% 3.2% 1.3% n= % 63.3% 25.8% 0.3% n=46 8.7% 67.4% 21.7% 2.2% NA 90 5

92 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n=1, % 63.3% 10.4% 0.3% n=56 a n=65 b n= % 26.2% 31.8% 73.2% 73.8% 67.8% 0.5% a n= % 64.6% 7.2% 0.6% b n= % 66.2% 0.6% 3.2% n= % 54.4% 25.1% n= % 63.0% 21.7% NA 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n=1, % n=56 1.8% a n= % 72.7% 98.2% 89.2% 10.7% 0.1% b n= % 87.2% 0.5% 0.5% a n= % 74.2% 7.7% 0.2% b n= % 68.2% 3.2% n= % % n= % 60.9% 23.9% NA 6 91

93 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n=1, % 70.9% 8.2% 0.1% n= % 80.4% a n=65 b n=211 a n= % 19.9% 19.2% 84.6% 79.6% 75.5% 0.5% 0.2% 5.2% b n= % 59.1% 2.6% n= % 62.3% 19.7% 0.3% n= % 60.9% 21.7% NA 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n=1, % 60.9% 21.8% 0.2% n= % 78.6% 7.1% a n= % 75.4% 7.7% b n= % 78.7% 2.8% a n= % 63.0% 17.5% 0.4% b n= % 66.2% 16.9% n= % 42.5% 42.5% 0.3% n= % 47.8% 37.0% NA 92 7

94 0% 20% 40% 60% 80% 100% n= n= n= n= n= n= n= n= n= NA 0% 20% 40% 60% 80% 100% n= n= n= n= n= n= n= n= n= NA 8 93

95 0% 20% 40% 60% 80% 100% n= n= n= n= n= n= n= n= n= NA 0% 20% 40% 60% 80% 100% n= n= n= n= n= n= n= n= n= NA 94 9

96 0% 20% 40% 60% 80% 100% n= n= n= n= n= n= n= n= n= NA 0% 20% 40% 60% 80% 100% n= n= n= n= n= n= n=242 n= n= NA 10 95

97 0% 20% 40% 60% 80% 100% n= n= n= n= n= n= n= n= n= NA 0% 20% 40% 60% 80% 100% n= n= n= n= n= n= n= n= n= NA 96 11

98 0% 20% 40% 60% 80% 100% n= n= n= n= n= n= n= n= n= NA 0% 20% 40% 60% 80% 100% n= n= n= n= n= n= n= n= n= NA 12 97

99 0% 20% 40% 60% 80% 100% n= n= n= n= n= n= n= n= n= NA 0% 20% 40% 60% 80% 100% n= n= n= n= n= n= n= n= n= NA 98 13

100 0% 20% 40% 60% 80% 100% n=1, % 69.8% 14.2% 0.1% n= % 68.2% 13.5% 0.6% n= % 78.6% n= % 77.8% 6.9% n=1, % 68.4% 15.8% NA 0% 20% 40% 60% 80% 100% n=1, % 71.6% 13.3% 0.2% n= % 12.4% n= % 71.4% n= % 81.5% 6.3% n=1, % 70.5% 14.8% 0.3% NA 98 99

101 0% 20% 40% 60% 80% 100% n=1, % 51.7% 9.6% 0.1% n= % 48.8% 10.6% n= % 71.4% n= % 54.0% 3.7% n=1, % 51.5% 10.7% 0.1% NA 0% 20% 40% 60% 80% 100% n=1, % 69.0% 12.9% 0.3% n= % 10.6% n= % 78.6% n= % 79.9% 7.9% 0.5% n=1, % 66.8% 14.3% 0.3% NA

102 0% 20% 40% 60% 80% 100% n=1, % 67.5% 12.4% 0.5% n= % 63.5% 1 1.2% n= % 64.3% n= % 81.5% 6.3% n=1, % 65.7% 14.0% 0.5% NA 0% 20% 40% 60% 80% 100% n=1, % 79.3% 0.3% 10.6% n= % 81.8% 10.6% n= % 78.6% n= % 89.9% 4.2% n=1, % 77.0% 11.9% 0.4% NA

103 0% 20% 40% 60% 80% 100% n=1, % 62.9% 11.2% 0.2% n= % 63.5% 1 n= % 7.1% n= % 76.7% 5.3% n=1, % 60.7% 12.6% 0.2% NA 0% 20% 40% 60% 80% 100% n=1, % 77.2% 10.6% 0.3% n= % 70.6% 11.2% n= % 85.7% n= % 85.2% 3.7% 0.5% n=1, % 76.6% 11.9% 0.3% NA

104 n=1,475 0% 20% 40% 60% 80% 100% 0.3% 26.0% 63.3% 10.4% n= % 10.6% 0.6% n= % 64.3% n= % 69.3% 4.8% n=1, % 62.8% 11.6% 0.3% NA 0% 20% 40% 60% 80% 100% n=1, % 72.7% 10.7% 0.1% n= % 65.3% 10.6% n= % 78.6% n= % 82.0% 3.7% n=1, % 72.1% 12.1% 0.2% NA

105 0% 20% 40% 60% 80% 100% n=1, % 70.9% 8.2% 0.1% n= % 65.3% 9.4% n= % 78.6% n= % 76.2% 3.7% 0.5% n=1, % 70.7% 8.9% 0.1% NA 0% 20% 40% 60% 80% 100% n=1, % 60.9% 21.8% 0.2% n= % % n=14 7.1% 85.7% 7.1% n= % 76.7% 12.7% n=1, % 57.9% 23.4% 0.3% NA

106 0% 20% 40% 60% 80% 100% n=1, % 69.8% 14.2% 0.1% n= % 78.1% 6.9% n= % 71.5% 11.7% n= % % 0.3% NA 0% 20% 40% 60% 80% 100% n=1, % 71.6% 13.3% 0.2% n= % 80.7% 5.9% 0.3% n= % 72.6% 10.8% 0.1% n= % 63.0% 23.3% 0.3% NA

107 0% 20% 40% 60% 80% 100% n=1, % 51.7% 9.6% 0.1% n= % 61.4% 3.3% n= % 50.8% 7.9% 0.1% n= % 45.6% 17.7% NA 0% 20% 40% 60% 80% 100% n=1, % 69.0% 12.9% 0.3% n= % 77.8% 5.2% n= % 68.5% 10.7% 0.3% n= % 63.3% 22.8% 0.5% NA

108 0% 20% 40% 60% 80% 100% n=1, % 67.5% 12.4% 0.5% n= % 74.8% 0.7% 5.6% n= % 67.7% 0.4% 1 n= % 61.3% 22.0% 0.5% NA 0% 20% 40% 60% 80% 100% n=1, % 79.3% 10.6% 0.3% n= % 87.3% 4.6% n= % 80.6% 8.3% 0.5% n= % 70.6% 19.5% NA

109 0% 20% 40% 60% 80% 100% n=1, % 62.9% 11.2% 0.2% n= % 69.9% 4.2% 0.3% n= % 64.1% 9.5% 0.1% n= % 55.4% 19.5% 0.3% NA 0% 20% 40% 60% 80% 100% n=1, % 77.2% 10.6% 0.3% n= % 84.3% 4.6% n= % 79.3% 8.4% 0.1% n= % 67.3% 19.2% 0.8% NA

110 0% 20% 40% 60% 80% 100% n=1, % 63.3% 10.4% 0.3% n= % 72.2% 4.2% 0.3% n= % 62.7% 8.3% 0.4% n= % 58.0% 19.2% NA 0% 20% 40% 60% 80% 100% n=1, % 72.7% 10.7% 0.1% n= % 81.7% 4.2% n= % 72.0% 8.3% 0.3% n= % 67.6% 2 NA

111 0% 20% 40% 60% 80% 100% n=1, % 70.9% 8.2% 0.1% n= % 75.8% 2.9% n= % 71.4% 6.2% 0.3% n= % 66.3% 15.9% NA 0% 20% 40% 60% 80% 100% n=1, % 60.9% 21.8% 0.2% n= % 71.6% 11.4% 0.3% n= % 62.3% 18.7% 0.3% n= % 50.1% 34.9% NA

112 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n=1, % 69.8% 14.2% 0.1% n= % 60.3% 7.6% n=1, % 70.5% 15.3% 0.1% NA 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n=1, % 71.6% 13.3% 0.2% n= % 70.2% 6.9% n=1, % 71.3% 14.3% 0.2% NA 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n=1, % 51.7% 9.6% 0.1% n= % 36.6% 5.3% n=1, % 52.8% 10.3% 0.1% NA

113 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n=1, % 69.0% 12.9% 0.3% n= % 62.6% 6.9% n=1, % 69.5% 13.9% 0.3% NA 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n=1, % 67.5% 12.4% 0.5% n= % 57.3% 6.1% n=1, % 68.8% 13.4% 0.5% NA 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n=1, % 79.3% 10.6% 0.3% n= % 72.5% 6.9% n=1, % 79.7% 11.3% 0.3% NA

114 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n=1, % 62.9% 11.2% 0.2% n= % 31.3% 6.9% n=1, % 65.8% 11.9% 0.2% NA 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n=1, % 77.2% 10.6% 0.3% n= % 71.0% 6.9% n=1, % 77.6% 11.2% 0.3% NA 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n=1, % 63.3% 10.4% 0.3% n= % 44.3% 6.9% n=1, % 64.9% 11.1% 0.3% NA

115 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n=1, % 72.7% 10.7% 0.1% n= % 62.6% 6.9% n=1, % 73.7% 11.4% 0.2% NA 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n=1, % 70.9% 8.2% 0.1% n= % 58.0% 5.3% n=1, % 72.6% 8.6% 0.2% NA 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% n=1, % 60.9% 21.8% 0.2% n= % 62.6% 10.7% 0.8% n=1, % 60.1% 23.6% 0.2% NA

116

117

118

119

120

121

122 121

123 122

124 123

125 124

126 125

127 126

128 127

129

130 129

131 130

132 131

133 132

134 133

135 134

136 135

137

138 137

139 138

140 139

141 140

142 141

143 142

144 143

145

146 145

147 146

148 147

149 148

150 149

151 150

152 151

153

154 153

155 154

156 155

157 156

158 157

159 158

160 159

161 160

162

163

164

165

166 165

167 166

168 167

169 168

170 169

171 170

172 171

173 172

174 173

175 174

176 175

177 176

178 177

179

180

レイアウト 1

レイアウト 1 1 1 3 5 25 41 51 57 109 2 4 Q1 A. 93% 62% 41% 6 7 8 Q1-(1) Q2 A. 24% 13% 52% Q3 Q3 A. 68% 64 Q3-(2) Q3-(1) 9 10 A. Q3-(1) 11 A. Q3-(2) 12 A. 64% Q4 A. 47% 47% Q5 QQ A. Q Q A. 13 QQ A. 14 Q5-(1) A. Q6

More information

10_11p01(Ł\”ƒ)

10_11p01(Ł\”ƒ) q q q q q q q q q q q q q q q q q q q q q q q q q qq q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q

More information

無印良品のスキンケア

無印良品のスキンケア 2 3 4 5 P.22 P.10 P.18 P.14 P.24 Na 6 7 P.10 P.22 P.14 P.18 P.24 8 9 1701172 1,400 1701189 1,000 1081267 1,600 1701257 2,600 1125923 450 1081250 1,800 1125916 650 1081144 1,800 1081229 1,500 Na 1701240

More information

untitled

untitled -- -- -3- % % % 6% % % 9 66 95 96 35 9 6 6 9 9 5 77 6 6 5 3 9 5 9 9 55 6 5 9 5 59 () 3 5 6 7 5 7 5 5 6 6 7 77 69 39 3 6 3 7 % % % 6% % % (: ) 6 65 79 7 3 36 33 9 9 5 6 7 3 5 3 -- 3 5 6 76 7 77 3 9 6 5

More information

untitled

untitled NO. 2007 10 10 34 10 10 0570-058-669 http://www.i-nouryoku.com/index.html (40 ) () 1 NO. 2007 10 10 2.2 2.2 130 70 20 80 30 () () 9 10 () 78 8 9 () 2 NO. 2007 10 10 4 7 3 NO. 2007 10 10 40 20 50 2 4 NO.

More information

104 100 60 9,195,336 409 0.004 24 8 31 9,025,983 568 0.006 2012 8 31 6,634,686 956 ( 0.014 ) 2 2011 8 26

104 100 60 9,195,336 409 0.004 24 8 31 9,025,983 568 0.006 2012 8 31 6,634,686 956 ( 0.014 ) 2 2011 8 26 25 25 3 5 MMR 1 104 100 60 9,195,336 409 0.004 24 8 31 9,025,983 568 0.006 2012 8 31 6,634,686 956 ( 0.014 ) 2 2011 8 26 2012 8 31 1,032,660 132 ( 0.013 ) 3 2010 6 11 3 11 15.4 1 1 ( ) 12 2 2 3 ER ) (

More information

1

1 1 1 2 3 4 5 6 7 8 9 10 11 Q7 3 0.0 10.0 20.0 30.0 40.0 50.0 18-29 30-39 40-49 12 Q8 Q7 0 20 40 60 23 23 13 14 15 16 Q10 3 0.0 20.0 40.0 60.0 80.0 18-29 30-39 40-49 17 18 Q12 3 0.0 10.0 20.0 30.0 40.0 18-29

More information

NIHSS score p NIHSS score p149 4 p g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml

NIHSS score p NIHSS score p149 4 p g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml NIHSS score14 1 400 1 p149 1 25 20 NIHSS score14 15 10 5 2 p149 4 p151 0 0.8 g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml 1 2 148 149 3 2 3 A B C 4 D 2 A B C A C 1 Ogata T et al J Neurol Sci 272 83 86 2008

More information

橡アロマセラピー症状別処方例.PDF

橡アロマセラピー症状別処方例.PDF 1 1 92 E 100ml 1 2 2 1 93 0.5m 10ml 100ml 1 2 3 2 52 0. l 2 4 3 27 3 1 1 3 3 4 5 3 2g 2 3 1 1 1 10ml 3 4 6 3 29 2 2 2 10ml 3 3 4 7 3 30 2 1 2 10ml 3 3 4 8 3 31 1 1 1 1 3 60 10 10 3 2 4 10ml A 2 3 61 20

More information

2005 1851 1909 1890 2007 37 24 36 37 38 280 39 40 SIDS SIDS 120kcal 41 22 267 20 1000 76.7 8500 609 972 524 60 19 2828 2.6 B2 42 24 700 43 44 10 45 18 10 17 39.7 46 12 47 20 30 76.7 85.8 66.8 26.6 21.7

More information

23 3 11 14 46 9.0 7 10m 40.1m 15,883 2,681 25 4 10 39 40 800 180 24 2425 22 21 24 5 3 21 24 10,899 20,472 13,723 33,007 667 400 79,167 8,620 11,694 10,089 25,131 690 215 56,439 13,614 20,897 15,200 32,213

More information

医療レーザー脱毛の威力と限界

医療レーザー脱毛の威力と限界 .... mm. CT WH W H W H W H... kcalkcal. 1. cal kcal 1 6 2 3. 4. 5. 1 6 6. B6 B12 B. BMI BMI30 C. D. kg mm . CT WH W H W H W H... kcalkcal . 1. cal kcal 1 6 2 3. 4. 5. 1 6 6. B6 B12 B. BMI BMI30 C. D.

More information

2 / 7

2 / 7 1 / 7 1.30 1.301.00m 2.00 2.001.00m 1.70 1.701.00m 2.4 2.41.0m 2.0 2.01.0m 1.08 1.20.9m 1.08 1.20.9m 2.5 2.51.0m 2.5 2.51.0m 0.9 1.00.9m 1.44 1.60.9m 2 / 7 ml ml 3 / 7 4 / 7 ) 5 / 7 6 / 7 0798-56-1710

More information

untitled

untitled 1 80 28 100 11 7-1- 2.49 1.89 1.29 0.69 1 1 10 50-2- 65 2 75 2 85 2 95 2 Aw -3- ( ) ( ) 5 5 0 10 ( ) ( ) ( ) -4- -5- 100 1 4 100 31 HACCP Hazard Analysis Critical Control Points 62 65 30-6- -7- -8- 100

More information

平成12年度 証券貯蓄に関する全国調査

平成12年度 証券貯蓄に関する全国調査 24.6 22.9 5.4 59.6 2.1 3.3 2.5 2.0 1.1 91.7 12.2 28.6 58.6 (NA:0.6) 32.9 30.7 12.3 3.3 4.5 49.5 87.6 61.5 5.1 58.7 48.9 10.5 5.9 8.6 14.9 0.8 20.8 8.8 6.8 2.5 2.2 5.5 25.6 10.4 8.9 9.4 9.0 11.8 9.3 8.7

More information

2 (1) (2) SCI 2 SCI 2 24 2 12 2

2 (1) (2) SCI 2 SCI 2 24 2 12 2 2004 (1) (2) (2) (3) (1) 1 (2) (3) 2 (1) (2) SCI 2 SCI 2 24 2 12 2 100% / 16 2002 2003 http://lin.lin.go.jp/alic/month/dome/1997/nov/chousa.htm (05 612 1315 1618 1922 2329 3039 4049 5059 60 ) =10 b g 1

More information

-51-

-51- -50- -51- 11 3 28 8 1 24 7 2 36 10 1-52- -53- 1 2-54- 6 1 2 3 4 5 6 6 1 19 5 200 300ml 20 6 400ml -55- -56- 10-57- 4 2 20-58- 2,500-59- -60- -61- 2-62- 6 3-63- 9 68 1 6-64- 3-65- 4-66- 5 6-67- -68- 1 1

More information

2006年3月8日

2006年3月8日 18 21 1990 2004 2 2005 14 15 2004 1990 2005 2003 300 7 2 1 2005 1972 100 40 6 1972 2004 197 6,500 2004 21 59 100 65 2007 5 2005 30 1.8 535.89 348.33 187.56 2006 2006 5 1 30 1 30 46 46 1 46 1000kl 4 1 100kl

More information

2 $ 0.41 $ 0.06 $ 0.44 $ (0.05) -- (0.05) (0.32) (0.02)

2 $ 0.41 $ 0.06 $ 0.44 $ (0.05) -- (0.05) (0.32) (0.02) NEWS RELEASE $ 3,214 $ 3,222 - $ 12,037 $ 11,968 1% $ 521 $ 461 13% $ 1,956 $ 1,867 5% $ 3,735 $ 3,683 1% $ 13,993 $ 13,835 1% $ 3,735 $ 3,407 10% $ 13,993 $ 12,933 8% $ 554 $ 86 549% $ 597 $ 1,501 (60)%

More information

,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,

,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1, 1 1 1 2 1 3 1 4 2 5 5 6 6 1 6 2 7 3 7 4 7 5 7 7 8 8 10 1 10 2 10 3 10 12 1 12 2 12 3 12 4 13 5 14 14 1 14 1 2 3 4 5 1 2 3 4 16 5 16 6 16 7 17 6 17 18 19~23-19- 1 0.5 1 43.25 2.20 3.60 103.50 43.88 2.20

More information

Microsoft Word - 観光と食 2・3 食品添加物 vs. 質の事業.doc

Microsoft Word - 観光と食 2・3 食品添加物 vs. 質の事業.doc 2 1. Ø 90 15 100 130 3 Ø Ø Ø Ø Ø ph Ø Ø ph Ø Na Na CMC OKINAWA UNIVERSITY 1/13 Na Na V.C ph ph Ø C g mg Ø ml g Ø Ø V.C g C mg 50kcal g Ø OKINAWA UNIVERSITY 2/13 Ø Ø Na Ø Ø Ø Ø Ø Ø Ø 1. 2. 3. 4. Ø OKINAWA

More information

2520 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% H20 4.7% 29.7% 46.6% 8.9% 8.1% 2.1% H25 0.7% 45.6% 33.8% 8.8% 5.1% 5.9% 16 14 12 10 8 6 4 2 0 y = 1.16x + 2.9 y = 0.54x + 6.35 2007 2008 2009 2010

More information

肝臓病教室201207v2配布用.pptx

肝臓病教室201207v2配布用.pptx 24 7 28 5 C C C C 11 1 vs 2 vs 1 0 1 600-1000mg 3-5/ 24,48 2448 12 1 1500-2250mg 6-9/ () 1 600-1000mg 3-5/ 0 24 88.1% 0 20 40 60 80 100 C ALT, GPT 30 34.4% ALT, GPT 0 20 40 60 80 100 2 , 2 3 1 1-100% 0

More information

財務情報

財務情報 50 Financial Information >> 52 54 66 68 69 71 72 51 2004 4,625,151 2,605,343 2,019,807 N/A 373,435 139,401 234,034 (7,603) 2005 2006 2007 2008 2008 4,664,514 4,637,657 4,769,387 6,409,727 $ 63,976 2,650,586

More information

1 川崎市長マニフェスト評価研究報告書表紙

1 川崎市長マニフェスト評価研究報告書表紙 1 2 3 5 5 10 11 13 15 17 20 42 47 50 88 89 90 1 () 2 2 2005 17 2008 20 3 2009 21 11 2008 20 4 20 14 70100 70 1 60 50 83100 83 35 27 77100 77 5 15 12 80% 10 9 5 3 5 3 3 8012 44 35 15 8 15 60%9 44 43 44

More information

評価結果報告書の概要版(平成20年度)

評価結果報告書の概要版(平成20年度) 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76

More information

8 8 0

8 8 0 ,07,,08, 8 8 0 7 8 7 8 0 0 km 7 80. 78. 00 0 8 70 8 0 8 0 8 7 8 0 0 7 0 0 7 8 0 00 0 0 7 8 7 0 0 8 0 8 7 7 7 0 j 8 80 j 7 8 8 0 0 0 8 8 8 7 0 7 7 0 8 7 7 8 7 7 80 77 7 0 0 0 7 7 0 0 0 7 0 7 8 0 8 8 7

More information

1 8 7 30 8 15 12 11 30 12 15 18 18 00 18 30 10 15 19 30 9 45 13 45 11 30 18 9 15 30 30 1 1 2

1 8 7 30 8 15 12 11 30 12 15 18 18 00 18 30 10 15 19 30 9 45 13 45 11 30 18 9 15 30 30 1 1 2 7 19 20 30 1 1 8 7 30 8 15 12 11 30 12 15 18 18 00 18 30 10 15 19 30 9 45 13 45 11 30 18 9 15 30 30 1 1 2 3 10 11 12 13 4 6 6 14 15 16 17 18 5 1 1 6 2 7 () 8 9 10 - 1 - - 2 - - 3 - - 4 - - 5 - - 6 - -

More information

@@ ;; QQ a @@@@ ;;;; QQQQ @@@@ ;;;; QQQQ a a @@@ ;;; QQQ @@@ ;;; QQQ a a a ; ; ; @ @ @ ; ; ; Q Q Q ;; ;; @@ @@ ;; ;; QQ QQ ;; @@ ;; QQ a a a a @@@ ;;; QQQ @@@ ;;; QQQ ;;; ;;; @@@ @@@ ;;; ;;; QQQ QQQ

More information

2013.10.13

2013.10.13 200 35 39.3 37 2013 http://www.bikenmaster.jp/ 2013.10.13 http://www.bikenmaster.jp/ 2013.10.13 http://www.bikenmaster.jp/ 2013.10.13 kg 0.096kcal 30 55kg 55(kg)0.096(kcal) 60()0.87() 276kcal 2029 1.00

More information

農林漁家民宿の女性経営者が

農林漁家民宿の女性経営者が 28 29 30 31 32 NA 33 NA 34 NA NA 35 NA 36 37 38 39 NA 40 41 NA NA 42 NA NA 43 NA NA 44 NA PR PR PR 45 PR PR PR PR FAX 46 FAX NA NA 47 NA NA 48 NA 49 NA 50 NA 51 NA NA 52 NA NA 53 GT NA 54 NA 55 NA 56 57

More information

橡35tsukiashi.PDF

橡35tsukiashi.PDF 1 1.1 1. 1 1.3.1..3. 3.1 3. 3.3 3. 3.5 1987 00 3 006 7 10 11 1 a. NPI.. 100 10 130 106 [ ] 5 NPI NPI 1986 1990 1 3 NPI 5 NPI 15 NPI A. B. C. D. E. F. G. A. B C. D. E. F. G. A. B. C. D. E. F. G. 1.. 3..

More information

:,, : - 7 -

:,, : - 7 - 31 ~ ~ - 6 - :,, : - 7 - (),,,,,,; ~ ~ *1 *2 6,,,~,,~ - 8-32 ,, ( );( ),,,,,, ~ ~ ~,,,, (),,,,, - 9 - 33 ~*~ ~~ ~, ~ ~ ~ ~ ~, ~~,,,, - 10 - BCG () g ) BCG BCG,, 34 ,,,, (),,,,,,,,,,,,,, () ( 3 90 [7 6

More information

Microsoft Word 年度DPCによるSPECT検査動向に関する報告 _02表紙.doc

Microsoft Word 年度DPCによるSPECT検査動向に関する報告 _02表紙.doc DPC SPECT 2 2013 9 DPC/PDPSDiagnosis Procedure Combination / Per-Diem Payment System 1 DPC DRG/PPS: Diagnosis Related Groups / Prospective Payment System 2003 2008 7 2008 DPC 2012 1,500 DPC SPECT 70% DPC

More information

                                       一休デイサービスセンター

                                       一休デイサービスセンター 2770105472 2770105472 2776300135 2776300135 - - 072-274-7219 072-204-7319 http://www.19day.jp/ 072-274-7219 072-204-7319 http://www.19day.jp/ 2007 11 1 45 2007 11 1 45 11 12 4km 10 11 -2- 3-3 - 4 - 5 11

More information

MAWGD08Y 5 5 5 5 5 5 6 5 5 6 6 7 5 6 7L 55L 5L 0L 8L 0.0 6.0.0.0 0.5 8 7 0 0 96ml 7ml 60ml 0ml ml 8ml 7ml 0ml 0ml ml 96 7 60 0 6ml ml 0ml 7ml ml 8ml 7ml 0ml 0ml ml 8 7 0 0 5 6 7 5 6 5 (0)890-750

More information

23 3 11 24 21 24 25 4 28 4 2 7 161 2,692 28 12 14 18 18 380 5 3 1 27 21 21 24 10,899 20,472 13,723 33,007 667 400 79,167 8,620 11,694 10,089 25,131 690 215 56,439 13,614 20,897 15,200 32,213 640 416 82,979

More information

d-00

d-00 283-0105 298 TEL. 0475-76-0839 FAX. 0475-76-0838 400g 300 4950399167708 14 220g 300 4950399066780 Page 1 300g 200 4950399066766 100 400g 300 4950399167722 350g 160 4950399066735 100 600g 350 4950399167685

More information

, 360ml P , 360ml P , 360ml P , 40, 720ml P , 14, 2

, 360ml P , 360ml P , 360ml P , 40, 720ml P , 14, 2 3-1 3-1 20 2600, 20, 360ml P.35 3-2 3-2 16 2700, 16, 280ml P.35 3-3 3-3 20 2600, 20, 360ml P.35 3-4 3-4 19 2600, 19, 340ml P.35 3-5 3-5 20 2900, 20, 360ml P.35 3-6 3-6 18 3000, 18, 320ml P.35 3-7 3-7 18

More information

A 01 2 015 10 11 12 G 011 2 0111 67

A 01 2 015 10 11 12 G 011 2 0111 67 66 A 01 2 015 10 11 12 G 011 2 0111 67 0119 0112 0113 68 0130 0128 0114 0113 0115 0116 0119 69 0111 0128 012 2 0121 1102 0122 0123 0124 70 0125 0126 0126 0111 0127 71 0128 0129 0230 013 0130 0130 011 012

More information

働く女性の母性健康管理、母性保護に関する法律のあらまし

働く女性の母性健康管理、母性保護に関する法律のあらまし 17 1 3 3 12 3 13 10 19 21 22 22 23 26 28 33 33 35 36 38 39 1 I 23 2435 36 4/2 4/3 4/30 12 13 14 15 16 (1) 1 2 3 (2) 1 (1) (2)(1) 13 3060 32 3060 38 10 17 20 12 22 22 500 20 2430m 12 100 11 300m2n 2n

More information

MAWN8UP MAWN7UP MAWN6UP 3 3 3 5 4 3 3 3 3 4 3 3 4 4 3 3 4 4 3 3 4 4 3 3 4 3 3 4 3 3 3 4 3 4 5 3 3 4 5 3 4 3 5 4 3 5 6 6 3 4 5 6 7 54 50 40 30 58 50 40 30 6 50 40 30 8.0 7.0 6.0 5.0 4.0.0 0.5 3 9

More information

Digital Photo Professional Ver1.6(Windows)

Digital Photo Professional Ver1.6(Windows) Windows CT1-5193-000 CANON INC. 2005 J 1 2 3 4 s s s 1 1 s s s s s 1 1 a s s 1 s s 1 2 s a 1 s a 2 3 1 1 s a a 2 a 3 a s s 1 a a s a s s 1 s s 1 2 3 s 1 1 a 2 a 1 a s 2 3 1 1 s a 2 1 3 1 s a 2

More information

<836C83628367834A8374834692B2B895F18145706466>

<836C83628367834A8374834692B2B895F18145706466> 1. 30 5 500 2 7 100 2 10 100 2007 4 1 7,200 6,800 7 NPO 1,200 1 12 15 2 1.5 0.5 30 2 24 5 27 16.8 28 2.3 10,500 / 3 3,800 117 2 3 6 6,000 1 1 1 2 2006 1 6, 000 + + 8 30 17 00 7.5 13 2 B2 2. 50 2 3 1 1

More information

23 3 11 21 24 28 4 31,371 20,822 34,511 21,720 12,278 9,574 7,502 137,778 1 69 83.49% 70 15.55% 0.96 3.61% 40 1.19% 1055 29.65% 28 10 1 2 230,250 43,150 656 138,000 137,832 137,820 121,000 30,000 246,800

More information

14-R-10 4 () () () () () () () () () 2 1) 2,700 106 4,783 50,000 4,600 345 6,495 100,000 2,400 393 2,972 50,000 3,500 1,235 5,910 100,000 1) 2) 3) (t) 0.5 ^ 5,000 =10 =2.29

More information

がん診療におけるFDG FDG-PET/CTの役割

がん診療におけるFDG FDG-PET/CTの役割 PET/CT PET/CT MRI PET PET/CT Kurashiki Central Hospital FDG-PET CT PET/CT (stage1) FDG-PET (stage1) PET/CT FDG-PET PET/CT (stage4) FDG-PET (stage4) PET/CT FDG-PET PET/CT PET/CT

More information

1 2 3 4 5 68g 9g 2g 0.2mg 0.8mg 316kcal 316cal 326kcal 326cal 6 010 3035 15 5355 30 120 20 7 8 9 10 11 () () () 12 1 3 1 5 1 80kcal 20 30 20 30 1 9 7.5 13 7.58.5 910.5 1213.5 11.512.5 14 15 79 23 1520

More information

パーキンソン-本文修正済.indd

パーキンソン-本文修正済.indd MIBG 107 LSI MIBG RI 1 SPECT MIBG 1 1 7 2-3-5 7 1-12 145 2215 1113-1-1 114 2713-1-30 5 7-1-1 6 9-1-1 401-1-11 131-2-50 10 2-15-1 2 1-2-54 43-1-1 2-10-10 1-10-1 2-1-1 1214-8 53 0166-22-8111 0166-51-3161

More information

Ⅱ 本編 19 1 23 1-1 - 16 - - 17-1-3 1-2 - 18 - - 19 - - 20 - - 21 - - 22 - 3 10 60 1,000 3,000-24 - 23.9% 19.2% 16.6% 37.4% 32.3% - 25 - 300500 27.6% 500700 21.0% 300 20.2% 7001,000 17.9% 1,000 13.3% 2-1-6-26

More information

4000/P4-25

4000/P4-25 4 5 ; ; ; ; ;; ; Q Q Q Q QQ Q ;; QQ ;Q ;; ;; QQ QQ ;; QQ Q ; Q;Q;Q ; 6 7 8 9 10 11 ; Q ;; QQ ;Q ;; QQ QQ ;; QQ ;; QQ ; Q 12 13 A ß ƒ u A A A 15 14 ;;;; ;;;; ;;;; ;;;; QQQQ QQQQ QQQQ QQQQ ;; ;; QQ QQ ;

More information

1-1 - 2 3-2 - - 3 - i - 4 - ii - 5 - c - 6 - 4 1-7 - 2 1-8 - 2-9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - 3-18 - - 19 - - 20 - - 21 - - 22 - - 23 - iii i - 24 - - 25 - - 26 - 4-27 - 5

More information

M.D.I VDT 29. (1)

M.D.I VDT 29. (1) 5. 5. 5.1 (1 (2 (3 (4 3040 5.2 32 1 1 43 2 44 3 45 13 14 1) 4 45 2 5 46 6 47 7 66 2 8 26 2 1 32 2) 1 2 53 3 39 4 40 5 56 6 29 7 38 8 22 9 22 3 48 2 29 5. 17 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14.

More information

のんべえにゅーす 1

のんべえにゅーす 1 1 Vol. 1 2001 12 20 Vol. 33 2003 2 4 http://www.kikuyashuhan.co.jp/shop/nonbei/mail.html PDF http://www.kikuyashuhan.co.jp/shop/shopping/index.html iii 7 15 iv 8 15 9 25 10 3 v vi 11 22 1 Vol. 1 2 http://www.kikuyashuhan.co.jp/fs-trade/shop01/user/1-a0010.html

More information

1.3 1.3.1., ( ) (, ).,,,.,. 1.3.2 ( ).,,,. 1 2.,.,.,.,.,.,,.. 2

1.3 1.3.1., ( ) (, ).,,,.,. 1.3.2 ( ).,,,. 1 2.,.,.,.,.,.,,.. 2 - - - - 1 1.1 3, 1.,, 2.,, 3.,,. 1: 2: 3:,.,.,. 1.2 >,.,. ==,. 100 %.

More information

2

2 1 2 3 1) 2) 3) 2 3 1 2 3 4 5 6 7 8 9 10 11 4 12 13 14 15 X 16 X 17 X CT 18 MRI 19 20 4 A. ENG T&T B. ABLB SISI ABR ASSRMLRSRL 5 5 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 6 1 2 3 4 7 1 POS( Problem

More information

g 51 52

g 51 52 10 12 A 12 C 12 13 13 13 13 16 16 18 18 18 23 23 23 23 23 A 24 25 25 26 28 28 30 32 38 38 41 42 43 10 43 11 45 48 48 120g 51 52 12 3 12 3 350g 120g 1 7 10 260g 90g 90g 30g 9 11 2 gg1 g 1 120g 10 1 12 6

More information

2

2 1 3 11 21 2 3 28 42 33 12 31 11 4 21 46.5 30.0vol 30 36 16 DXNs 46 19 B 42 22 5 0.44 10 15 20 20 1.5 1.5 0.1 0.37 6 4.5 1.7 16 1.5 1.5 4.5 1.5 7 3.6 4.4 12 8 1.5 9 46 19 19 10 500ml 11 33 3.6 3.9 12 2.1

More information

20●12頁●6-14▲放射線科▲.ppt

20●12頁●6-14▲放射線科▲.ppt No.268 Katayama H. et al. Adverse reactions to ionic and nonionic contrast media-a report from the Japanese Committee of the Safety of Contrast Media. Radiology 1990;175:621-628. 12.66% 3.13% 0.22% 0.04%

More information

10K1A NASA () SPACE ATLAS Freedom H2A NASA 1

10K1A NASA () SPACE ATLAS Freedom H2A NASA 1 10O1A 10 10 1 10K1A NASA () SPACE ATLAS 40 1957 1969 10 1986 1990 Freedom 20 000 H2A NASA 1 10K1A 100 10 21 40 1996 ( 200 () 2 10S1A 10 8 57 250 1 10S1A 20 200mmm 2 10S1B 18 18 1 10S1B 40 10 20 2 10S1C

More information

2005 DE-9PF-N DE-9SF-N DA-15PF-N DA-15SF-N DB-25PF-N DB-25SF-N DC-37PF-N DC-37SF-N DD-50PF-N DD-50SF-N DE-9PF-N DC-37PF-N DA-1

2005 DE-9PF-N DE-9SF-N DA-15PF-N DA-15SF-N DB-25PF-N DB-25SF-N DC-37PF-N DC-37SF-N DD-50PF-N DD-50SF-N DE-9PF-N DC-37PF-N DA-1 25 U S SB M M 9 9 P P 0.2 ML ML E RS232C A 15 15 15 UL 25 S U UL RS232C 9PM 9PM E A 0.2 X 0000000 3,342 120 180 300 3,370 120 180 300 3,361 120 180 300 4,664 164 210 551 4,626 164 210 551 6,064 226 290

More information

E-mail rsakurai@jade.dti.ne.jp 2000. 2. 1-1-

E-mail rsakurai@jade.dti.ne.jp 2000. 2. 1-1- E-mail rsakurai@jade.dti.ne.jp 2000. 2. 1-1- LD LD LD -2- MBD Minimal Brain Dysfunction Syndrome -3- Minimal Brain Dysfunction Syndrome : --- WISC-WPPSIK-ABC --- CTMRIEEG --- 40 60-4- -5- MBD MBD MBD MBD

More information

untitled

untitled FACT BOOK CONTENTS PAR T 1 1 2 2003 3 4 4 5 PAR T PAR T 1 6 2 7 7 8 9 1 10 2 11 3 12 4 13 5 14 14 PAR T 1 15 2 16 3 17 PAR T 1 18 2 18 3 21 21 1 PART 1 2200200kcal 1 2 3 A 1 2 Q1 3 4 5 4 201010 P ART PART

More information

表紙.PDF

表紙.PDF 2000 21 21 21 1990 21 1997 21 2001 1 21 ( ) () (21 ) 2 1 3 2 4 1 1974 2 5 3 100ml 20kcal 6 4 5 15581570 1920 211 1927 7 8 6 7 9 10 2-1 500ml PET 2-2 1998 11 2-3 1998 2-4 t 2000 12 1 13 2 2000 10 14

More information

untitled

untitled ( 1,000 1 0562-92-8317 0562-93-8105 12 1000 133015303/25 10 700 90011303/30 100 0 100011303/25 1 30 2 30 3 1 12 5 3000 7000 9001130 5/135/276/37/88/5 1 2 35 2 10 5 3000 5000 3 9001130 6/86/227/68/249/21

More information

NEDO

NEDO 10 MRI 1 1 595% 5 IOR 100% MRI MRI MRI MRI MRI MRI 11 MRI 3 2 1 MRI 1 1.5 0.000005 100 5 MRI MRI MRI MRI MRI MRI MRI MRI MRI (1) MRI MRI 0.3 3 MRI 1 / (2) MRI MRI (3)MRI MRI 3 (4)MRI MRI MRI (5)MRI 2006

More information

0.01mg/ ç 0.01 mg/ ç 0.01 mg/ ç 0.01 mg/ ç 0.05 mg/ ç 0.05 mg/ ç 0.01 mg/ ç 0.01 mg/ ç 0.0005mg/ ç 0.0005mg/ ç 0.02 mg/ ç 0.02 mg/ ç 0.002 mg/ ç 0.002 mg/ ç 0.004 mg/ ç 0.004 mg/ ç 0.02 mg/ ç 0.02 mg/

More information

44-1(前11)7回春季大会

44-1(前11)7回春季大会 PET 5 18 5 20 5 18 5 20 5 18 5 20 5 18 5 20 5 18 17:10 18:35 19 5 18 20 URL: http://www.t-inform.co.jp/jsnm-s7/ 7 http://www.t-inform.co.jp/jsnm-s7/ 7 19 5 18 20 7 7 PET PET PET RI 2 19 PET PET PET 1

More information

天草郡市医師会第139回(臨時)代議員会

天草郡市医師会第139回(臨時)代議員会 A 97 2(B A2) 4(A B3) 2 95 B 104 25(A B3) 16(B A2) 9 113 201 27 20 7 208 2 1 13 3 18 4 19 3 3 2 2 13 4 17 3 18 6 26 6 30 17 18 17 17 17 17 18 ( ) 18 ( ) 18 ( ) 18 ( ) 18 ( ) ( ) ( ) ( ) ( ) ( ) 18 ( ) (

More information